Tavanta Therapeutics
Phase 1Tavanta Therapeutics is a clinical stage specialty pharmaceutical company developing a broad pipeline of specialty drugs for patients with high unmet needs.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $250M
About
Tavanta Therapeutics is a clinical stage specialty pharmaceutical company developing a broad pipeline of specialty drugs for patients with high unmet needs.
OncologySmall Molecules
Funding History
2Total raised:$250M
Series B$150MMar 15, 2023
Series A$100MSep 15, 2021